| 000 | 02912cam a2200361 4500500 | ||
|---|---|---|---|
| 005 | 20250121142928.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aLe Divenah, Aude _eauthor |
| 700 | 1 | 0 |
_a David, Stéphane _eauthor |
| 700 | 1 | 0 |
_a Brignone, Mélanie _eauthor |
| 700 | 1 | 0 |
_a Chau, Ingrid _eauthor |
| 700 | 1 | 0 |
_a Segouin, Christophe _eauthor |
| 700 | 1 | 0 |
_a Kauffmann, Clarisse _eauthor |
| 700 | 1 | 0 |
_a Benabdelmoumen, Ghania _eauthor |
| 700 | 1 | 0 |
_a Shelly, Marc _eauthor |
| 700 | 1 | 0 |
_a Régnier, Christian _eauthor |
| 700 | 1 | 0 |
_a Sellier, Pierre _eauthor |
| 700 | 1 | 0 |
_a Bertrand, Dominique _eauthor |
| 245 | 0 | 0 | _aHealthcare Management and Follow-Up of Patients Treated with Antiretroviral Prophylaxis: An Evaluation of Professional Practices |
| 260 | _c2010. | ||
| 500 | _a70 | ||
| 520 | _aThe care management of patients treated for cases of sexual or blood exposure requires stringent clinical and biological follow-up procedures. Despite the provision of information about the importance of regular follow-up, the number of patients dropping out of screening consultations at the Hospital Lariboisière-Fernand Widal (Assistance Publique-Hôpitaux de Paris) has increased. The main purpose of this study is to improve follow-up for patients treated with anti-retroviral prophylaxis following a known sexual or blood exposure. An investigation based on 5 markers of a targeted clinical audit form (“drop-outs” or lost to follow-up, conduct of HIV serology tests, traceability of clinical, biological and compliance monitoring) was carried out. A review of practices was conducted on the basis of an analysis of patient cases over a six-month period, followed by the implementation and evaluation of corrective measures over a two-year period.A significant decline in the number of patients lost to follow-up was observed. The study shows a significant improvement in other markers: serological follow-up, compliance traceability, and clinical and biological monitoring. These results were observed between 2005 and 2007. Two distinctive effects were identified: improvement in patient care management and the quality of care, and the empowerment of actors, thereby ensuring a certain continuity of action. The decline in the rate of lost to follow-up patients and improved monitoring of compliance and iatrogenic risks confirm these effects. The overall approach is incorporated into an evaluation of professional practices. | ||
| 690 | _aHuman Immunodeficiency Virus | ||
| 690 | _aevaluation of professional practices | ||
| 690 | _alost to follow-up | ||
| 690 | _atargeted clinical audit | ||
| 690 | _acompliance | ||
| 690 | _aclinical tolerance | ||
| 690 | _aanti-retroviral prophylaxis | ||
| 786 | 0 | _nSanté Publique | 22 | 4 | 2010-09-15 | p. 393-403 | 0995-3914 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-sante-publique-2010-4-page-393?lang=en&redirect-ssocas=7080 |
| 999 |
_c585803 _d585803 |
||